Literature DB >> 23830506

Reflections on the role of the pharmacy regulatory authority in enhancing quality related event reporting in community pharmacies.

Todd A Boyle1, Andrea C Bishop2, Thomas Mahaffey2, Neil J Mackinnon3, Darren M Ashcroft4, Bev Zwicker5, Carolyn Reid2.   

Abstract

BACKGROUND: Given the demanding nature of providing pharmacy services, coupled with the expanded scope of practice of the professions in jurisdictions around the world, greater commitment to continuous quality improvement through adoption of quality-related event (QRE) reporting is necessary to ensure patient safety. Pharmacy regulatory authorities (PRAs) are in a unique position to enhance QRE reporting and learning through the standardization of expected practice.
OBJECTIVE: This study was aimed to gain a better understanding of the perceived roles of PRAs in enhancing QRE reporting and learning in community pharmacies, and identifying regulatory best practices to execute such roles.
METHODS: A purposive case sampling approach was used to identify PRA staff members from two groups (Deputy registrars and pharmacy inspectors) in 10 Canadian jurisdictions to participate in focus groups in the fall of 2011. Focus groups were used to explore perceptions of the role of PRAs in enhancing and promoting QRE reporting and learning, and perceived barriers to effective implementation in practice. Thematic analysis was used to analyze the qualitative data.
RESULTS: Two focus groups were conducted, one with seven Deputy registrars/Practice managers, and one with nine pharmacy inspectors. Five themes were identified, including (1) defining QRE reporting and compliance, (2) navigating role conflict, (3) educating for enhanced QRE reporting and learning, (4) promoting the positive/removing the fear of QREs, and (5) tailoring QRE reporting and learning consistency.
CONCLUSIONS: Overall, participants perceived a strong role for PRAs in enhancing QRE reporting and learning and providing education for pharmacies to support their compliance with reporting standards. However, PRAs must navigate the conflict inherent in both educating and promoting a process for achieving a standard while simultaneously inspecting compliance to that standard. Ensuring pharmacies have autonomy in operationalizing standards may help to mitigate this conflict. Finally, greater education for PRAs themselves to better inspect compliance and in order to better communicate the benefits of QRE reporting and learning to pharmacies would be beneficial.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Pharmacy administration; Qualitative research; Quality assurance; Quality related events

Mesh:

Year:  2013        PMID: 23830506      PMCID: PMC5021532          DOI: 10.1016/j.sapharm.2013.06.002

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  11 in total

1.  Workforce cultural factors in TQM/CQI implementation in hospitals.

Authors:  Z Huq; T N Martin
Journal:  Health Care Manage Rev       Date:  2000

2.  Results of the Arizona Medicaid health information technology pharmacy focus groups.

Authors:  Terri L Warholak; Anita Murcko; Megan McKee; Terry Urbine
Journal:  Res Social Adm Pharm       Date:  2010-11-18

3.  Challenges of standardized continuous quality improvement programs in community pharmacies: the case of SafetyNET-Rx.

Authors:  Todd A Boyle; Neil J MacKinnon; Thomas Mahaffey; Kellie Duggan; Natalie Dow
Journal:  Res Social Adm Pharm       Date:  2012-03-14

Review 4.  Collecting and analysing qualitative data: issues raised by the focus group.

Authors:  J Sim
Journal:  J Adv Nurs       Date:  1998-08       Impact factor: 3.187

5.  How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives.

Authors:  Kritsanee Saramunee; Janet Krska; Adam Mackridge; Jacqueline Richards; Siritree Suttajit; Penelope Phillips-Howard
Journal:  Res Social Adm Pharm       Date:  2012-10-23

6.  Keeping the "continuous" in continuous quality improvement: exploring perceived outcomes of CQI program use in community pharmacy.

Authors:  Todd A Boyle; Andrea C Bishop; Kellie Duggan; Carolyn Reid; Thomas Mahaffey; Neil J MacKinnon; Amelia Mahaffey
Journal:  Res Social Adm Pharm       Date:  2013-03-23

7.  The role of hidden curriculum in teaching pharmacy students about patient safety.

Authors:  Fay Bradley; Alison Steven; Darren M Ashcroft
Journal:  Am J Pharm Educ       Date:  2011-09-10       Impact factor: 2.047

8.  Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.

Authors:  Ingunn Mandt; Anne Marie Horn; Anders Ekedahl; Anne Gerd Granas
Journal:  Res Social Adm Pharm       Date:  2009-07-29

9.  Continuing professional development in pharmacy.

Authors:  Michael J Rouse
Journal:  J Am Pharm Assoc (2003)       Date:  2004 Jul-Aug

Review 10.  Using focus groups to inform pharmacy research.

Authors:  Sally A Huston; Eric H Hobson
Journal:  Res Social Adm Pharm       Date:  2008-08-08
View more
  4 in total

1.  How CEO Deans in Academic Pharmacy Describe and Manage High-performing and Low-performing Faculty.

Authors:  Shane P Desselle; David P Zgarrick
Journal:  Innov Pharm       Date:  2020-01-30

2.  Assessing the scale of adoption of sustainability practices by community pharmacies in Spain in the time of COVID-19.

Authors:  Belén Derqui; Viachaslau Filimonau; Jorge Matute
Journal:  Sustain Prod Consum       Date:  2021-04-02

3.  Pharmacists' Perceptions of the Barriers and Facilitators to the Implementation of Clinical Pharmacy Key Performance Indicators.

Authors:  Laura V Minard; Heidi Deal; Megan E Harrison; Kent Toombs; Heather Neville; Andrea Meade
Journal:  PLoS One       Date:  2016-04-04       Impact factor: 3.240

4.  Defining clinical pharmacy and support activities indicators for hospital practice using a combined nominal and focus group technique.

Authors:  Hugo Lopes; Andrea Rodrigues Lopes; Helena Farinha; Ana Paula Martins
Journal:  Int J Clin Pharm       Date:  2021-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.